Drug Research

Transcenta, a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, and Merck, a leading science and technology company, have announced a strategic technology collaboration to implement continuous manufacturing for protein therapeutics at CIIE. “To...

Oxford Biomedica plc , a leading gene and cell therapy group and PhoreMost Limited, the UK-based biopharmaceutical company dedicated to developing drugs against intractable disease targets, announced that they have entered into a discovery collaboration to develop next-generation CAR-T...

Thermo Fisher Scientific Inc., the world leader in serving science, and Innoforce, a bioinnovation-enabling company, announced they have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China, for integrated biologics and steriles drug...

Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced the expansion of its Maryland campus to accommodate the company’s rapid growth as it works to develop its candidate vaccine against COVID-19 and advance its...

aTyr Pharma, Inc. , a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, announced that it has entered into a research collaboration with the Medical University of South Carolina (MUSC). Dr....

Intec Pharma Ltd. announces it has entered into a new research collaboration agreement with MSD, the tradename of Merck & Co., Inc., Kenilworth, NJ, USA. Details of the agreement are confidential. "We are very excited to continue to work with...

Thermo Fisher Scientific announced it signed a partnership agreement with the newly formed Terasaki Innovation Center (TIC) to facilitate discovery and development of new pathways and tools to diagnose and better manage transplant patients. The mission of the TIC is...